Merck KGaA Finds The Right Home For Disease-Modifying OA Agent In Novartis

Licenses Nanobody M6495 To Swiss Firm

 
• By John Davis
  
Osteoarthritis
Reversing Osteoarthritis Changes Has Proven Difficult • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business